HIV/AIDS Prevention
Phase 3 trial of vaginal gel for HIV prevention stopped in Ghana
Published in Medical Letter on the CDC and FDA, December 4th, 2005
As part of this initiative, with funding from the U.S. Agency for International Development (USAID), Family Health International (FHI) and Cellegy Pharmaceuticals, Inc., have been working to see if a vaginal gel called Savvy is effective in preventing male-to-female transmission of HIV among women at high risk of infection in West Africa. Other organizations are conducting trials in the United States to determine if Savvy is effective as a contraceptive.
Family Health International and Cellegy Pharmaceuticals announced that they plan...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Genomics & Genetics
Two monkeypox virus clades identified - Glioblastoma Multiforme
FDA approval summary for temozolomide plus radiation for glioblastoma multiforme released - Lipid Studies
Total and LDL cholesterol levels decreasing in U.S. adults - Outbreaks
Hepatitis B outbreak linked to frequent injections at doctor's office - Smallpox Vaccine
Efficacy of diluted smallpox vaccine remains high when stored on ice - Addiction Medicine
New findings in the area of addiction medicine detailed - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
